The pharmaceutical landscape for diabetes is changing, and GLP-1 patches represent a exciting advance. Unlike shots, this approach offers a more convenient way to administer GLP-1 drugs. These transdermal systems gradually release the drug through the skin offering a consistent dose of the benefi